33 min
Dr. Joe Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB) The Green Rush is real.
-
- Business News
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.
This week Anne Donohoe and Nick Opich talk to Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel neuroplastogen therapeutics for the treatment of neuropsychiatric disorders. Dr. Tucker joins us to discuss the latest news and milestones for the company, including the selection of EB-003 as its lead candidate in its EVM 301 series, plus advice to the retail investor audience on continuing drug discovery investments in the psych space.
In this episode, Joe and our hosts also discuss psychedelic companies that are leveraging AI and how Enveric’s proprietary AI technology PsyAI™ integrates into the biotech’s research processes.
If you are interested in learning more about Joe and Enveric, visit the links in our show notes. Also, be sure to follow Enveric Biosciences on LinkedIn and X.
So, sit back and enjoy our conversation with Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB).
Links, mentions, and socials:
Enveric Biosciences: https://www.enveric.com
“30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond - Enveric Biosciences (NASDAQ:ENVB), Cybin (AMEX:CYBN) - Benzinga”
Enveric Biosciences LinkedIn: https://www.linkedin.com/company/EnvericBio
Enveric Biosciences X: https://twitter.com/Enveric_bio
Show Credits:
This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
X: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: linkedin.com/company/thegreenrushpodcast
Facebook: facebook.com/TheGreenRushPodcast
YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.
This week Anne Donohoe and Nick Opich talk to Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel neuroplastogen therapeutics for the treatment of neuropsychiatric disorders. Dr. Tucker joins us to discuss the latest news and milestones for the company, including the selection of EB-003 as its lead candidate in its EVM 301 series, plus advice to the retail investor audience on continuing drug discovery investments in the psych space.
In this episode, Joe and our hosts also discuss psychedelic companies that are leveraging AI and how Enveric’s proprietary AI technology PsyAI™ integrates into the biotech’s research processes.
If you are interested in learning more about Joe and Enveric, visit the links in our show notes. Also, be sure to follow Enveric Biosciences on LinkedIn and X.
So, sit back and enjoy our conversation with Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB).
Links, mentions, and socials:
Enveric Biosciences: https://www.enveric.com
“30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond - Enveric Biosciences (NASDAQ:ENVB), Cybin (AMEX:CYBN) - Benzinga”
Enveric Biosciences LinkedIn: https://www.linkedin.com/company/EnvericBio
Enveric Biosciences X: https://twitter.com/Enveric_bio
Show Credits:
This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
X: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: linkedin.com/company/thegreenrushpodcast
Facebook: facebook.com/TheGreenRushPodcast
YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
33 min